Balatti Veronica, Oghumu Steve, Bottoni Arianna, Maharry Kati, Cascione Luciano, Fadda Paolo, Parwani Anil, Croce Carlo, Iwenofu O Hans
Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, USA.
Department of Pathology and Laboratory Medicine, The Ohio State University, Columbus, USA.
Head Neck Pathol. 2019 Sep;13(3):344-354. doi: 10.1007/s12105-018-0971-x. Epub 2018 Sep 26.
Salivary duct carcinomas (SDC) and Her2/Neu3-overexpressing invasive breast carcinomas (HNPIBC/IBC) are histologically indistinguishable. We investigated whether common histopathologic and immunophenotypic features of SDC and IBC are mirrored by a similar microRNA (miRNA) profile. MiRNA profiling of 5 SDCs, 6 IBCs Her2/Neu3+, and 5 high-grade ductal breast carcinoma in situ (DCIS) was performed by NanoString platform. Selected miRNAs and HOXA1 gene were validated by RT-PCR. We observed similar miRNA expression profiles between IBC and SDC with the exception of 2 miRNAs, miR-10a and miR-142-3p, which were higher in IBC tumors. DCIS tumors displayed increased expression of miR-10a, miR-99a, miR-331-3p and miR-335, and decreased expression of miR-15a, miR-16 and miR-19b compared to SDC. The normal salivary gland and breast tissues also showed similar expression profiles. Interestingly, miR-10a was selectively increased in both IBC and normal breast tissue compared to SDC and normal salivary gland tissue. Moreover, our NanoString and RT-PCR data confirmed that miR-10a was upregulated in IBC and DCIS compared to SDC. Finally, we show downregulation of HOXA1, a miR-10 target, in IBC tumors compared to normal breast tissue. Taken together, our data demonstrates that, based on miRNA profiling, SDC is closely related to HNPIBC. Our results also suggest that miR-10a is differentially expressed in IBC compared to SDC and may have potential utility as a diagnostic biomarker in synchronous or metachronous malignant epithelial malignancies involving both organs. In addition, miR-10a could be playing an important role as a mammary-specific oncogene, involved in breast cancer initiation (DCIS) and progression (IBC), through mechanisms that include modulation of HOXA1 gene expression.
涎腺导管癌(SDC)与过表达人表皮生长因子受体2/神经氨酸酶3(Her2/Neu3)的浸润性乳腺癌(HNPIBC/IBC)在组织学上难以区分。我们研究了SDC和IBC常见的组织病理学和免疫表型特征是否反映在相似的微小RNA(miRNA)谱中。通过NanoString平台对5例SDC、6例Her2/Neu3阳性的IBC和5例高级别导管原位癌(DCIS)进行了miRNA谱分析。通过逆转录-聚合酶链反应(RT-PCR)对选定的miRNA和HOXA1基因进行了验证。我们观察到IBC和SDC之间的miRNA表达谱相似,但有2种miRNA(miR-10a和miR-142-3p)除外,它们在IBC肿瘤中表达较高。与SDC相比,DCIS肿瘤中miR-10a、miR-99a、miR-331-3p和miR-335的表达增加,而miR-15a、miR-16和miR-19b的表达降低。正常涎腺组织和乳腺组织也显示出相似的表达谱。有趣的是,与SDC和正常涎腺组织相比,miR-10a在IBC和正常乳腺组织中均选择性增加。此外,我们的NanoString和RT-PCR数据证实,与SDC相比,miR-10a在IBC和DCIS中上调。最后,我们发现与正常乳腺组织相比,IBC肿瘤中miR-10的靶基因HOXA1表达下调。综上所述,我们的数据表明,基于miRNA谱分析,SDC与HNPIBC密切相关。我们的结果还表明,与SDC相比,miR-10a在IBC中差异表达,可能作为涉及两个器官的同步或异时性恶性上皮性肿瘤的诊断生物标志物具有潜在应用价值。此外,miR-10a可能作为乳腺特异性癌基因发挥重要作用,通过包括调节HOXA1基因表达在内的机制参与乳腺癌的起始(DCIS)和进展(IBC)。